- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01452204
Pulsed Electromagnetic Field (PEMF) in Impingement Shoulder (PEMF)
Pulsed Electromagnetic Field in Patients With Impingement Shoulder: A Randomized, Placebo-Controlled Clinical Trial
In the past many authors have reported the abnormal contact between the rotator cuff and coracoacromial arch, but the exact etiology was not clearly understood. Thus, the objectives of this study relate specifically to improve the symptoms and rehabilitation of shoulder function of the patient:
- Assess the effectiveness of magnet therapy in the treatment of impingement of the rotator cuff;
- Assess whether the application of magnetic therapy 3 times a week for three weeks, may be effective as a single treatment of impingement of the rotator cuff;
- Assess whether the combination of magnetic therapy with therapeutic exercises is more effective than magnetic therapy only;
- Evaluate the benefits of magnetic therapy associated with therapeutic exercise in the short and long term.
- Assess the effectiveness of the modulation of pulsed electromagnetic field at 25 Hz and 20 mT in patients with shoulder impingement syndrome.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Randomization of the patients 1.1) Duration of wash-out Having made the proper screening of patients undergoing the study, all pre-selected patients should discontinue any medications that might influence the symptoms of impingement syndrome (such as analgesics, antiinflammatory, chondroprotective, etc.) for a period of 7 days.
1.2) Randomization
The investigators have chosen a total sample of 30 patients undergoing the study. Only one will be treated the shoulders of patients, if there are cases of bilateral impingement syndrome (IS). Patients will be equally distributed in two groups, receiving first place:
Group 1: treatment with magnetic therapy, three times per week lasting 30 minutes each session.
Group 2: placebo of magnet therapy (MT), three times per week lasting 30 minutes each session.
Randomization will be done as follows: initially 10 patients will be selected to be evaluated by a blinded evaluator and by the end of the evaluation, the patient will randomly choose a paper folded into 2 parts, which will be inside a plastic bag. Inside this bag there will be 10 paper folded in the same way and with the same color and size, where in three of them will say "A", two of them written in "B", three of them written in "C" and two of them "D" . Patients were drawn papers written "A" and "D" will be selected for group 1 and patients to raffle papers written "B" and "C" will be selected for group 2. After the drawing paper, the same can not be placed back in the bag. Randomization will be done this way so that all patients can also be divided into two groups and for the blind assessor does not know which group the patient was allocated.
- PLAN OF STUDY 2.1) Assessment 1: Patients selected for study are those referred to our outpatient musculoskeletal physiotherapy with a diagnosis of impingement syndrome grade II and grade III. All will be evaluated by a blinded investigator, who uses the Visual Analogue Scale (VAS), the rating scale of Constant and University of California, Los Angeles (UCLA) shoulder rating scale, and measurement of rotator cuff muscle force (external and internal rotation) and shoulder elevation.
2.2) Assessment 2: After 3 weeks of treatment only with the applications of magneto therapy, a new assessment will be equal to an evaluation made by an assessor blinded, who do not know which patients are exposed to placebo or not. After the third evaluation, all patients will continue with the sessions of magnetic therapy (placebo or not), but now associated with specific therapeutic exercises for the treatment of impingement syndrome of the shoulder. The assessment consists of two re-evaluation of all parameters previously in an evaluation.
2.3) Evaluation 3: The third evaluation will happen after three weeks of treatment with magnetic therapy and exercises over again a blind assessor will evaluate patients in the same manner as in evaluation 1 and 2. After this evaluation, patients receive high treatment and receive a booklet of exercises to help them to practice proper exercises for the shoulder at home.
2.4) Evaluation 4: The fourth review will occur six months after the third evaluation, where the main objective is to evaluate the efficacy of treatment without the guidance of a physiotherapist and without weekly applications of magnetic therapy.
- Application of methods: The investigators have chosen a total sample of 30 patients undergoing the study. Only one will be treated the shoulders of patients, if there are cases of bilateral impingement syndrome. Patients will be equally distributed in two groups, receiving first place: Group 1: treatment with magnetic therapy, three times per week lasting 30 minutes each session. Group 2: placebo of magnet therapy, three times per week lasting 30 minutes each session.After the first 3 weeks of application of magnetic therapy, will begin a program of therapeutic exercises (kinesiotherapy) equally to all patients in both groups. These exercises will be conducted after each application of magnetic therapy and all patients will receive a brochure guiding them to perform exercises at home. The applications of magnetic therapy will continue to be 3 times per week with 30 minutes duration each application, but this time associated with exercise, treatment will be done for another 4 weeks. After these four weeks, patients will be reassessed by the scale of Constant and UCLA to evaluate the overall function of the shoulders that received placebo treatment and the magneto.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
SP
-
são Paulo, SP, Brazil, 01221-020
- Irmandade Da Santa Casa De Misericordia De Sao Paulo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- The patient must have a diagnosis of impingement of the rotator cuff grade II or grade III. For patients with grade III, they must present at least 90 ° of active elevation of the affected shoulder-free. Patients with extensive lesions of the rotator cuff will be deleted.
- The patient must be aged between 30 and 50 years, of both sexes.
- Patients should not use any anti-inflammatory, analgesic and / or chondroprotective by at least one week before the start of treatment.
- The patient must not have been subjected to intra-articular injection of corticosteroids for at least 30 days before the start of treatment.
- The patient can not be being subjected to physical therapy for at least 30 days before the start of treatment.
- Patient must have at least 3 months of discomfort and / or symptoms of impingement syndrome.
Exclusion Criteria:
- Make use of systemic anti-inflammatory medications and / or topics during the study.
- Patient presenting during pregnancy or postpartum.
- A patient with cancer, even if you are treated.
- Having been subjected to surgery on the shoulder to receive the study treatment
- submit inflammatory joint diseases (such as rheumatoid arthritis, lupus, gout, etc.) except for the impingement of the rotator cuff.
- Patients who do not submit high active-free up to 90 degrees (minimum) of the affected shoulder will be deleted. These cases are specific to patients with extensive lesions of the rotator cuff and have no function of this muscle group.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
|
G1: MT, three times per week lasting 30' each session.
G2: placebo MT, 3 X week lasting 30'each session.
After 3 weeks of application of MT, will begin a program of exercises.
Other Names:
|
Experimental: Pulsed Electromagnetical Field
|
G1: MT, three times per week lasting 30' each session.
G2: placebo MT, 3 X week lasting 30'each session.
After 3 weeks of application of MT, will begin a program of exercises.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rotator cuff muscle force
Time Frame: 3 weeks after exercise
|
Patients selected are those referred with a diagnosis of impingement syndrome grade II and III.
All will be evaluated by a blinded investigator, who uses measurement of rotator cuff muscle force after 3 weeks of exercise treatment.
|
3 weeks after exercise
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rotator cuff muscle force
Time Frame: 3 months post-exercise follow up
|
Patients selected are those referred with a diagnosis of impingement syndrome grade II and III.
All will be evaluated by a blinded investigator, who uses the measurement of rotator cuff muscle force
|
3 months post-exercise follow up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Diego DG Galace, Study Chair, Faculdade de Ciências Médicas da Santa Casa de São Paulo
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PEMF01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Impingement Shoulder
-
CHU de ReimsTerminatedSubacromial Impingement of the ShoulderFrance
-
Copenhagen University Hospital, HvidovreUniversity of Copenhagen; Aalborg University; Metropolitan University CollegeCompletedSubacromial Impingement SyndromeDenmark
-
Cairo UniversityNot yet recruitingShoulder ImpingementEgypt
-
Uskudar UniversityCompletedShoulder ImpingementTurkey
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Texas Tech University Health Sciences CenterCompletedThe Pull Test To Determine Responders To Subacromial Injection In Patients With Shoulder ImpingementShoulder Impingement SyndromeUnited States
-
National Taiwan University HospitalCompletedShoulder ImpingementTaiwan
-
Romano Orthopaedic CenterCompleted
-
Uskudar State HospitalNot yet recruitingSubacromial Impingement Syndrome | Shoulder Impingement Syndrome | Shoulder Pain | Subacromial Impingement | Shoulder Impingement
-
Hadassah Medical OrganizationUnknownShoulder Impingement Syndrome.
Clinical Trials on Pulsed Electromagnetical Field and Exercise
-
Horus UniversityCompletedOsteo Arthritis Knee | Ultrasound Therapy; ComplicationsEgypt
-
Suleyman Demirel UniversityCompletedMuscle Stretching Exercise | Muscle Injury | Pulsed Electromagnetic TherapyTurkey
-
Umm Al-Qura UniversityCompletedOsteopenia or OsteoporosisSaudi Arabia
-
Chinese University of Hong KongActive, not recruitingKnee Osteoarthritis | SarcopeniaHong Kong
-
Mona Mohamed TahaRecruitingVenous Leg UlcerEgypt
-
Jordan University of Science and TechnologyCompletedKnee OsteoarthritisJordan
-
Umm Al-Qura UniversityCompletedOsteopenia or OsteoprosisSaudi Arabia
-
Walaa Abd Elaziem Abd ElazizRecruiting
-
Shanghai MicroPort EP MedTech Co., Ltd.Active, not recruitingParoxysmal Supraventricular TachycardiaChina
-
Ningbo No. 1 HospitalCompletedParoxysmal Supraventricular TachycardiaChina